James Bradner biography
Dr. James (Jay) Bradner, M.D., has served as President of the Novartis Institutes for BioMedical Research (NIBR) and Member of the Executive Committee of Novartis Inc. since March 1, 2016. He joined Novartis in January 2016. Prior to joining Novartis, Dr. Bradner was on the faculty of Harvard Medical School in the Department of Medical Oncology at the Dana-Farber Cancer Institute in the United States from 2005 through 2015. He is a co-founder of five biotechnology companies and has authored more than 180 scientific publications and 30 US patent applications. Dr. Bradner is a graduate of Harvard University and the University of Chicago Medical School in the United States. He completed his residency in medicine at Brigham and Women’s Hospital and his fellowship in medical oncology and hematology at the Dana-Farber Cancer Institute. He has been honored with many awards and was elected into the American Society for Clinical Investigation in 2011 and the Alpha Omega Alpha Honor Medical Society in 2013.
What is the salary of James Bradner?
As the President of the Novartis Institutes for BioMedical Research (NIBR) and Member of the Executive Committee of Novartis AG, the total compensation of James Bradner at Novartis AG is $6,308,280. There are 1 executives at Novartis AG getting paid more, with Vasant Narasimhan having the highest compensation of $11,437,500.
